These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 4594415)

  • 1. Rosette-plaque assay: fine specificity differences among individual hapten-primed lymph node cells.
    Bankert RB; Wolf B
    J Immunol; 1974 May; 112(5):1782-92. PubMed ID: 4594415
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous expression of hapten binding and antibody secretion by NIP-primed lymph node cells early in the immune response.
    Bankert RB; Wolf B
    J Immunol; 1973 Dec; 111(6):1790-9. PubMed ID: 4796102
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic competition at the cellular level: response of rabbit lymph node cells to the trinitrophenyl and p-arsanilic hapTENS.
    Fauci AS; Johnson JS
    J Immunol; 1971 May; 106(5):1396-8. PubMed ID: 4930070
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-hapten response in vitro. Affinity differences in precursors of anti-hapten antibody-producing cells.
    Pasanen VJ; Virolainen M
    Eur J Immunol; 1971 Nov; 1(5):406-8. PubMed ID: 4945641
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological unresponsiveness against the 4-hydroxy-3,5-dinitro-phenacetyl (NNP) hapten in different lymphoid cell populations.
    Möller E; Sjöberg O; Mäkelă O
    Eur J Immunol; 1971 Jun; 1(3):218-20. PubMed ID: 4942472
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the hapten-carrier specificity of lymphocyte transformation.
    Warnatz H; Scheiffarth F
    Int Arch Allergy Appl Immunol; 1971; 41(1):122-6. PubMed ID: 4104661
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on antibody avidity at the cellular level. Effects of immunological paralysis and administered antibody.
    Andersson B; Wigzell H
    Eur J Immunol; 1971 Nov; 1(5):384-90. PubMed ID: 4945639
    [No Abstract]   [Full Text] [Related]  

  • 8. 2,4-dinitrophenyl-hapten specific hemolytic plaque-in-gel formation by mouse myeloma (MOPC-315) cells.
    Yamada H; Yamada A; Hollander VP
    J Immunol; 1970 Jan; 104(1):251-5. PubMed ID: 4904002
    [No Abstract]   [Full Text] [Related]  

  • 9. Strain differences in the fine specificity of mouse anti-hapten antibodies.
    Imanishi T; Mäkelä O
    Eur J Immunol; 1973 Jun; 3(6):323-30. PubMed ID: 4586168
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody formation against 2,4-dinitrophenyl-hapten at the cellular level. Hemolytic plaque-in-gel assay for lymphoid cells producing anti-2,4-dinitrophenyl-hapten antibody.
    Yamada H; Yamada A
    J Immunol; 1969 Aug; 103(2):357-63. PubMed ID: 4979592
    [No Abstract]   [Full Text] [Related]  

  • 11. [Production of antibodies with 2 specificities by individual mouse cells].
    Liacopoulos P; Couderc J; Bleux C; Birrien JL
    Ann Immunol (Paris); 1974 Jan; 125C(1-2):267-70. PubMed ID: 4142555
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of antigen dose on stimulation of anti-hapten plaque forming cells of different affinities.
    Pasanen VJ
    Int Arch Allergy Appl Immunol; 1971; 40(1):153-60. PubMed ID: 4926141
    [No Abstract]   [Full Text] [Related]  

  • 13. Transformation of rat lymph node cells by simian virus 40: attempt to "fix" specialized function.
    Collins JJ; Bloch KJ; Black PH
    J Natl Cancer Inst; 1970 Dec; 45(6):1097-104. PubMed ID: 4098902
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation of dinitrofluorobenzene-treated sheep erythrocytes for detection of anti-DNP plaque-forming cells.
    Trump GN
    J Immunol; 1972 Oct; 109(4):754-60. PubMed ID: 4116358
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular events in tolerance. II. Similar specificity of carrier cross-tolerance in vivo and cross-stimulation in vitro.
    Scott DW
    J Immunol; 1974 Apr; 112(4):1354-9. PubMed ID: 4131164
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody-binding characteristics at the cellular level. I. Comparative maturation of hapten-specific IgM and IgG plaque-forming cell populations.
    Claflin L; Merchant B; Inman J
    J Immunol; 1973 Jan; 110(1):241-51. PubMed ID: 4568183
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on actively allergised cells. 3. Suppression of the allergic response with specific antibody and the effect of this treatment on plaque and rosette-forming cells.
    McConnell I
    Int Arch Allergy Appl Immunol; 1971; 40(2):287-304. PubMed ID: 4926255
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte proliferation in vitro induced by hapten autologous protein conjugates. I. A study on the class of lymphocytes responding in vitro and on the nature and specificity of their receptors.
    Rubin B; Wigzell H
    J Exp Med; 1974 Mar; 139(3):732-53. PubMed ID: 4591177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic selection of IgG precursor subpopulations.
    Elliott LH; Roszman TL
    J Immunol; 1975 Aug; 115(2):495-501. PubMed ID: 1097518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The allogeneic effect: increased affinity of serum antibody produced during a secondary response.
    Elfenbein GJ; Green I; Paul WE
    Eur J Immunol; 1973 Oct; 3(10):640-4. PubMed ID: 4587739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.